Evidence map›Paper›PMID 24584631›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2014

Carbon-carbon bond cleavage in activation of the prodrug nabumetone.

Fatbardha Varfaj, Siti N A Zulkifli, Hyoung-Goo Park, Victoria L Challinor, James J De Voss, Paul R Ortiz de Montellano

Abstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. SelectiveACS catalysis · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Practical Catalytic Cleavage of C(spAngewandte Chemie (International ed. in English) · 2019
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Fatbardha VarfajDepartment of Pharmaceutical Chemistry, University of California, San Francisco, California (F.V., H.P., P.R.O.M.); Department of Chemistry, University of Queensland, St. Lucia, Brisbane, Australia (S.N.A.Z., V.L.C., J.J.D.V.); and Department of Biological Sciences, Konkuk University, Seoul, Korea (H.P.).
Siti N A Zulkifli
Hyoung-Goo Park
Victoria L Challinor
James J De Voss
Paul R Ortiz de Montellano
University of Queensland · AUKonkuk University · KRUniversity of California, San Francisco · US

Funding

SELECTIVE DESTRUCTION OF CYTOCHROME P450 BY DRUGSR01GM025515 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1985 to 2014
$5.6M
NIGMS NIH HHS R01 GM025515NIGMS NIH HHS R01 GM25515
6 · The paper itself

Abstract

Carbon-carbon bond cleavage reactions are catalyzed by, among others, lanosterol 14-demethylase (CYP51), cholesterol side-chain cleavage enzyme (CYP11), sterol 17β-lyase (CYP17), and aromatase (CYP19). Because of the high substrate specificities of these enzymes and the complex nature of their substrates, these reactions have been difficult to characterize. A CYP1A2-catalyzed carbon-carbon bond cleavage reaction is required for conversion of the prodrug nabumetone to its active form, 6-methoxy-2-naphthylacetic acid (6-MNA). Despite worldwide use of nabumetone as an anti-inflammatory agent, the mechanism of its carbon-carbon bond cleavage reaction remains obscure. With the help of authentic synthetic standards, we report here that the reaction involves 3-hydroxylation, carbon-carbon cleavage to the aldehyde, and oxidation of the aldehyde to the acid, all catalyzed by CYP1A2 or, less effectively, by other P450 enzymes. The data indicate that the carbon-carbon bond cleavage is mediated by the ferric peroxo anion rather than the ferryl species in the P450 catalytic cycle. CYP1A2 also catalyzes O-demethylation and alcohol to ketone transformations of nabumetone and its analogs.

Indexed as

BiocatalysisBiotransformationButanonesChromatography, High Pressure LiquidCyclooxygenase 2 InhibitorsCytochrome P-450 CYP1A2Escherichia coliHumansIn Vitro TechniquesMicrosomesNabumetoneNaphthaleneacetic AcidsOxidation-ReductionProdrugsSubstrate SpecificityTransfection6-methoxy-2-naphthylacetic acidButanonesCyclooxygenase 2 InhibitorsCYP1A2 protein, humanCytochrome P-450 CYP1A2NabumetoneNaphthaleneacetic AcidsProdrugs

Identifiers

PMID24584631
PMCPMC3989788
OpenAlexW2111816290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.